Vascular diseases and bleedings

Handb Clin Neurol. 2017:146:207-236. doi: 10.1016/B978-0-12-804279-3.00013-7.

Abstract

Diseases of the central nervous system that are caused by an underlying vascular pathology typically result in either hemorrhage or ischemia. Most prominent entities include spontaneous subarachnoid hemorrhage, spontaneous intracerebral hemorrhage, and ischemic stroke. For anatomic reasons, cerebrospinal fluid (CSF) qualifies as body fluid for the exploration of biomarkers in these disorders. Even though in subarachnoid hemorrhage a few CSF parameters have been established for routine diagnostic purposes, there is still an unmet need and broad interest in the identification of molecules that would allow further insight into disease mechanisms and supplement patients' medical care. This chapter provides an overview on what is presently known about CSF biomarkers in spontaneous subarachnoid hemorrhage, spontaneous intracerebral hemorrhage, and ischemic stroke. We recapitulate current evidence on established diagnostic tests, discuss the role of various CSF molecules in the pathophysiology of these diseases, and illuminate their potential use in future clinical practice. Furthermore, we address methodologic aspects as well as shortcomings of research in this field.

Keywords: biomarker; cerebral infarction; cerebral vasospasm; cerebrospinal fluid; delayed cerebral ischemia; intracerebral hemorrhage; ischemic stroke; subarachnoid hemorrhage.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / cerebrospinal fluid
  • Brain Ischemia / cerebrospinal fluid*
  • Brain Ischemia / diagnosis
  • Humans
  • Inflammation Mediators / cerebrospinal fluid*
  • Stroke / cerebrospinal fluid*
  • Stroke / diagnosis
  • Subarachnoid Hemorrhage / cerebrospinal fluid*
  • Subarachnoid Hemorrhage / diagnosis
  • Vascular Diseases / cerebrospinal fluid
  • Vascular Diseases / diagnosis

Substances

  • Biomarkers
  • Inflammation Mediators